ImpriMed
AI-driven precision medicine predicting chemotherapy effectiveness for pet cancer treatment.
About ImpriMed
ImpriMed uses live cancer cell testing combined with AI trained on real clinical outcomes to predict which chemotherapy drugs will be most effective for individual dogs with lymphoma or leukemia. The platform predicts responses for 13 anticancer drugs and reports a median prediction accuracy of 87.5%. With over 3,700 patients tested and 10,000+ samples analyzed, ImpriMed represents one of the most advanced applications of AI in veterinary oncology, helping veterinary oncologists make data-driven treatment decisions for their patients.
Key Features
- Live cancer cell testing with AI prediction
- Predicts responses for 13 anticancer drugs
- 87.5% median prediction accuracy
- Personalized treatment recommendations
- Lymphoma and leukemia coverage
- Results inform treatment protocol selection
Pricing
Per-test
Target Audience
Veterinary oncologists and specialty hospitals
Category
🔬 Diagnostics & Imaging
AI tools for radiology interpretation, pathology, and diagnostic imaging.
Looking for a Veterinary AI Scribe?
PawfectNotes records your appointments and automatically generates SOAP notes, discharge instructions, and more. Free to get started — no credit card required.